Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 37, 2014, Pages 13505-13510

  Satow, Reiko ^a,b   Hirano, Tamaki ^a   Batori, Ryosuke ^a   Nakamura, Tomomi ^a   Murayama, Yumi ^a   Fukami, Kiyoko ^a,b  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CDH1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOLIPASE C DELTA;

ADENOCARCINOMA; CARCINOGENESIS; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; DOWN REGULATION; ENZYMOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; CADHERINS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHOLIPASE C DELTA; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84907286219     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1405374111     Document Type: Article

References (31)

1. Heinemann V, Douillard JY, Ducreux M, PeetersM (2013) Targeted therapy in metastatic colorectal cancer - an example of personalised medicine in action. Cancer Treat Rev 39(6):592-601.
2. Láng I, et al. (2013) Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin. Eur J Cancer 49(2):439-448.
3. Normanno N, et al. (2009) Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol 6(9):519-527.
4. Zenonos K, Kyprianou K (2013) RAS signaling pathways, mutations and their role in colorectal cancer. World J Gastrointest Oncol 5(5):97-101.
5. Agbunag C, Bar-Sagi D (2004) Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Res 64(16):5659-5663.
6. Rachagani S, et al. (2011) Activated KrasGD is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. Br J Cancer 104(6):1038-1048.
7. Yang YR, Follo MY, Cocco L, Suh PG (2013) The physiological roles of primary phospholipase C. Adv Biol Regul 53(3):232-241.
8. Danielsen SA, et al. (2011) Phospholipase C isozymes are deregulated in colorectal cancer-insights gained from gene set enrichment analysis of the transcriptome. PLoS ONE 6(9):e24419.
9. Seifert JP, Zhou Y, Hicks SN, Sondek J, Harden TK (2008) Dual activation of phospholipase C-epsilon by Rho and Ras GTPases. J Biol Chem 283(44):29690-29698.
10. Li M, Edamatsu H, Kitazawa R, Kitazawa S, Kataoka T (2009) Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis. Carcinogenesis 30(8):1424-1432
11. Wang X, et al. (2012) Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol 29(2):1051-1058.
12. Buck E, et al. (2007) Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 6(2):532-541.
13. Shitashige M, et al. (2008) Regulation of Wnt signaling by the nuclear pore complex. Gastroenterology 134(7):1961-1971.
14. Satow R, et al. (2012) β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells. Gastroenterology 142(3):572-581.
15. Conacci-Sorrell M, et al. (2003) Autoregulation of E-cadherin expression by cadherincadherin interactions: The roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163(4):847-857.
16. Lugli A, et al. (2007) Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: A tissue microarray-based analysis. Histopathology 50(4):453-464.
17. Kim NG, Koh E, Chen X, Gumbiner BM (2011) E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA 108(29):11930-11935.
18. Lau MT, Klausen C, Leung PC (2011) E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression. Oncogene 30(24):2753-2766.
19. Shin SI, Freedman VH, Risser R, Pollack R (1975) Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci USA 72(11):4435-4439.
20. Laprise P, Langlois MJ, Boucher MJ, Jobin C, Rivard N (2004) Down-regulation of MEK/ ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J Cell Physiol 199(1):32-39.
21. Chen X, et al. (2012) Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Mol Biol Rep 39(6):6707-6714.
22. Mohri Y (1997) Prognostic significance of E-cadherin expression in human colorectal cancer tissue. Surg Today 27(7):606-612.
23. Roger L, Jullien L, Gire V, Roux P (2010) Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci 123(Pt 8):1295-1305.
24. Makrodouli E, et al. (2011) BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: A comparative study. Mol Cancer 10:118.
25. Onder TT, et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68(10):3645-3654.
26. Nakamura Y, et al. (2003) Phospholipase Cdelta1 is required for skin stem cell lineage commitment. EMBO J 22(12):2981-2991.
27. Chakrabarty S, Radjendirane V, Appelman H, Varani J (2003) Extracellular calcium and calcium sensing receptor function in human colon carcinomas: Promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res 63(1):67-71.
28. Ilyas M, Straub J, Tomlinson IP, Bodmer WF (1999) Genetic pathways in colorectal and other cancers. Eur J Cancer 35(14):1986-2002.
29. Kanemaru K, et al. (2012) Epidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice. Nat Commun 3:963.
30. Kouchi Z, Fujiwara Y, Yamaguchi H, Nakamura Y, Fukami K (2011) Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells. Biochem Biophys Res Commun 408(4):523-529.
31. Hirano T, et al. (2013) Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness. Biochem Pharmacol 86(10):1419-1429.